Friday, January 03, 2014 11:30:53 AM
Why are they delisting? Haven't read anything related
Please see: http://www.sec.gov/Archives/edgar/data/1289340/000135445713000211/xslF25X02/primary_doc.xml
I think I might have misunderstood this filing by the SEC.
To continue being listed on NASDAQ the regular bid price must be above $1 and the market cap above $50M. STXS does meet those conditions, so I dont know why the SEC filed Form 25.
Thanks for challenging my post. Any other clarifications would be appreciated.
Please see: http://www.sec.gov/Archives/edgar/data/1289340/000135445713000211/xslF25X02/primary_doc.xml
I think I might have misunderstood this filing by the SEC.
To continue being listed on NASDAQ the regular bid price must be above $1 and the market cap above $50M. STXS does meet those conditions, so I dont know why the SEC filed Form 25.
Thanks for challenging my post. Any other clarifications would be appreciated.
Recent STXS News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 11:15:30 AM
- Stereotaxis Announces Definitive Agreement to Acquire Robocath • GlobeNewswire Inc. • 04/15/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 10:22:35 PM
- Stereotaxis Announces FDA Clearance and Launch of Synchrony System • GlobeNewswire Inc. • 04/06/2026 12:06:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/03/2026 09:00:37 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2026 01:04:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 10:04:07 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/23/2026 04:15:16 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/13/2026 08:24:52 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:52:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:05:44 PM
- Stereotaxis Reports 2025 Full Year Financial Results • GlobeNewswire Inc. • 03/09/2026 08:01:00 PM
- Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 • GlobeNewswire Inc. • 02/12/2026 02:00:00 PM
- Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter • GlobeNewswire Inc. • 01/06/2026 01:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:15:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:15:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:15:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 09:15:22 PM
- Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference • GlobeNewswire Inc. • 11/24/2025 01:58:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 08:39:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:00:47 PM
- Stereotaxis Reports 2025 Third Quarter Financial Results • GlobeNewswire Inc. • 11/11/2025 09:01:00 PM
- GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance • GlobeNewswire Inc. • 11/10/2025 09:05:00 PM
